BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9060564)

  • 1. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88.
    De Zen L; Sommaggio A; d'Amore ES; Masiero L; di Montezemolo LC; Linari A; Madon E; Dominici C; Bosco S; Bisogno G; Carli M; Ninfo V; Basso G
    J Clin Oncol; 1997 Mar; 15(3):1198-205. PubMed ID: 9060564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in childhood rhabdomyosarcoma.
    San Miguel-Fraile P; Carrillo-Gijón R; Rodriguez-Peralto JL; Badiola IA
    Am J Clin Pathol; 2004 Mar; 121(3):358-65. PubMed ID: 15023040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy as a prognostic factor in rhabdomyosarcoma. Analysis of 35 cases with image cytometry.
    Pohar-Marinsek Z; Bracko M; Lavrencak J; Us-Krasovec M
    Anal Quant Cytol Histol; 2003 Aug; 25(4):235-42. PubMed ID: 12961831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.
    Pappo AS; Crist WM; Kuttesch J; Rowe S; Ashmun RA; Maurer HM; Newton WA; Asmar L; Luo X; Shapiro DN
    J Clin Oncol; 1993 Oct; 11(10):1901-5. PubMed ID: 8410116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
    Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.
    Shapiro DN; Parham DM; Douglass EC; Ashmun R; Webber BL; Newton WA; Hancock ML; Maurer HM; Look AT
    J Clin Oncol; 1991 Jan; 9(1):159-66. PubMed ID: 1985166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis.
    Kilpatrick SE; Teot LA; Geisinger KR; Martin PL; Shumate DK; Zbieranski N; Russell GB; Fletcher CD
    Cancer; 1994 Dec; 74(12):3227-33. PubMed ID: 7526971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators.
    Niggli FK; Powell JE; Parkes SE; Ward K; Raafat F; Mann JR; Stevens MC
    Br J Cancer; 1994 Jun; 69(6):1106-10. PubMed ID: 8198978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas.
    Wijnaendts LC; van der Linden JC; van Diest P; van Unnik AJ; Delemarre JF; Voûte PA; Meijer CJ
    J Clin Pathol; 1993 Oct; 46(10):948-52. PubMed ID: 8227415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content and proliferative activity in pediatric genitourinary rhabdomyosarcoma.
    San Miguel-Fraile P; Carrillo-Gijón R; Rodríguez-Peralto JL; Ortiz-Rey JA; Alvarez-Alvarez C; de la Fuente-Buceta A
    Pediatr Pathol Mol Med; 2003; 22(2):143-52. PubMed ID: 12556294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of DNA ploidy in childhood rhabdomyosarcoma.
    Jung WH; Jung SH; Yoo CJ; Kim YJ; Park C; Kim BS
    Yonsei Med J; 1994 Mar; 35(1):34-42. PubMed ID: 8009895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
    Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
    Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
    Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
    Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyosarcoma. Morphologic, immunohistochemical, and DNA study.
    Gruchała A; Niezabitowski A; Wasilewska A; Sikora K; Ryś J; Szklarski W; Jaszcz A; Lackowska B; Herman K
    Gen Diagn Pathol; 1997 Feb; 142(3-4):175-84. PubMed ID: 9065581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
    Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
    J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.